Biologics Spine Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds byTim AllenMarch 11, 2026
Biologics Spine Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery byJosh SandbergMarch 10, 2026
Financial Spine First-of-its-kind study: Analysis finds prior authorization delays elective spine surgery without cutting costs byTim AllenMarch 2, 2026
Biologics Spine Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion byJosh SandbergFebruary 12, 2026
Recon Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology byTim AllenFebruary 12, 2026
Recon Spine Genesys Spine Announces Positive Prospective Study Results for SIros® Lateral SI Joint Fusion System byTim AllenFebruary 6, 2026
Biologics Spine Study Shows NanoFuse® Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone byJosh SandbergJanuary 26, 2026
Spine Pain Physician Study Shows Percutaneous Hydrogel Implant for Chronic Low Back Pain Improves Patients’ Pain and Function byTim AllenJanuary 23, 2026
Spine Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal byJosh SandbergJanuary 7, 2026
